Phase I study of roniciclib (BAY1000394), an oral CDK inhibitor in Japanese patients with advanced solid tumors

被引：0
|
作者：
Seto, Takashi [1 ]
Nosaki, Kaname [1 ]
Shinoda, Gen [2 ]
Hashizume, Kensei [2 ]
Yamaguchi, Iku [2 ]
Tsuburaya, Jun [2 ]
Nogai, Hendrik [3 ]
Shitara, Kohei [4 ]
Yoh, Kiyotaka [4 ]
机构：
[1] Kyushu Natl Canc Ctr, Fukuoka, Japan
[2] Bayer Yakuhin Ltd, Osaka, Japan
[3] Bayer Pharma AG, Berlin, Germany
[4] Natl Canc Ctr Hosp East, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O3-5-3
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Results of a phase 1 study of MEK162, an oral MEK inhibitor, in Japanese patients with advanced solid tumors
    Shimokata, T.
    Watanabe, K.
    Shibata, T.
    Inada-Inoue, M.
    Shirao, K.
    Hirashima, Y.
    Fukuhara, S.
    Tokushige, K.
    Zubel, A.
    Ando, Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S870 - S871
  • [32] A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors
    Saeki T.
    Takashima S.
    Terashima M.
    Satoh A.
    Toi M.
    Osaki A.
    Toge T.
    Ohno S.
    Nomura N.
    Fukuyama Y.
    Koizumi W.
    Taguchi T.
    International Journal of Clinical Oncology, 2005, 10 (1) : 51 - 57
  • [33] A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors
    Wataru Okamoto
    Takayuki Yoshino
    Toshiaki Takahashi
    Isamu Okamoto
    Shinya Ueda
    Asuka Tsuya
    Narikazu Boku
    Kazuto Nishio
    Masahiro Fukuoka
    Nobuyuki Yamamoto
    Kazuhiko Nakagawa
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 1063 - 1071
  • [34] A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors
    Okamoto, Wataru
    Yoshino, Takayuki
    Takahashi, Toshiaki
    Okamoto, Isamu
    Ueda, Shinya
    Tsuya, Asuka
    Boku, Narikazu
    Nishio, Kazuto
    Fukuoka, Masahiro
    Yamamoto, Nobuyuki
    Nakagawa, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (05) : 1063 - 1071
  • [35] PHASE I STUDY OF LY2523355, AN EG5 INHIBITOR, IN JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS
    Nakamichi, S.
    Nokihara, H.
    Mizugaki, H.
    Wakui, H.
    Fujiwara, Y.
    Yamada, Y.
    Yamamoto, N.
    Suzuki, K.
    Akinaga, S.
    Tamura, T.
    ANNALS OF ONCOLOGY, 2013, 24
  • [36] Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors
    Shinji Nakamichi
    Hiroshi Nokihara
    Noboru Yamamoto
    Yasuhide Yamada
    Yutaka Fujiwara
    Yosuke Tamura
    Hiroshi Wakui
    Kazunori Honda
    Hidenori Mizugaki
    Satoru Kitazono
    Yuko Tanabe
    Hajime Asahina
    Naoya Yamazaki
    Shigenobu Suzuki
    Mieko Matsuoka
    Yoshitaka Ogita
    Tomohide Tamura
    Investigational New Drugs, 2015, 33 : 641 - 651
  • [37] Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors
    Nakamichi, Shinji
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Yamada, Yasuhide
    Fujiwara, Yutaka
    Tamura, Yosuke
    Wakui, Hiroshi
    Honda, Kazunori
    Mizugaki, Hidenori
    Kitazono, Satoru
    Tanabe, Yuko
    Asahina, Hajime
    Yamazaki, Naoya
    Suzuki, Shigenobu
    Matsuoka, Mieko
    Ogita, Yoshitaka
    Tamura, Tomohide
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (03) : 641 - 651
  • [38] Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors
    Mross, Klaus
    Stefanic, Martin
    Gmehling, Daniela
    Frost, Annette
    Baas, Franziska
    Unger, Clemens
    Strecker, Ralph
    Henning, Juergen
    Gaschler-Markefski, Birgit
    Stopfer, Peter
    de Rossi, Lothar
    Kaiser, Rolf
    CLINICAL CANCER RESEARCH, 2010, 16 (01) : 311 - 319
  • [39] Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors
    O'Donnell, Anne
    Faivre, Sandrine
    Burris, Howard A., III
    Rea, Daniel
    Papadimitrakopoulou, Vassiliki
    Shand, Nicholas
    Lane, Heidi A.
    Hazell, Katharine
    Zoellner, Ulrike
    Kovarik, John M.
    Brock, Cathryn
    Jones, Suzanne
    Raymond, Eric
    Judson, Ian
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) : 1588 - 1595
  • [40] Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
    Oh, Do-Youn
    Lee, Se-Hoon
    Han, Sae-Won
    Kim, Mi-Jung
    Kim, Tae-Min
    Kim, Tae-You
    Heo, Dae Seog
    Yuasa, Miyuki
    Yanagihara, Yasuo
    Bang, Yung-Jue
    CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 607 - 615
12345